• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2022.17006

Depression symptoms after comprehensive treatment with general magnetotherapy

[Psychiatry]
Ivan Nikolaevich Bakhmutsky; Viktor G. Kosenko; Nikolay Georgievich Bakhmutsky;

The work compared the effectiveness of the depression treatment in two formed groups of 103 patients (control – 50, main – 53 patients). For comparison, treatment with antidepressants alone was used in the control group, and antidepressants were combined with general magnetotherapy in the main group. The effectiveness of treatment after four weeks was assessed by the severity of depression using the Hamilton scale (HDRS). In the group where magnetotherapy was used in treatment, there were significantly more patients who achieved remission (on the Hamilton scale ≤7 points) than in the group where treatment was carried out only with antidepressants, with magnetotherapy – 28 patients, without it – 18 patients (p<0.01). In the main group, the symptoms such as «suicidal thoughts» (reduction by 80.65 %), «early insomnia» by 70.91%, late insomnia by 72.50 %, as well as anxiety and lethargy. Therapy of depression with antidepressants in combination with general magnetotherapy is well tolerated by patients, there are no undesirable side effects, and high efficiency allows us to recommend this method of treatment for use in the clinic.

Download

References:
1. WHO Depression data fact sheet. Geneva: World Health Organization, 2020. Available from: http://www.who.int/mediacentre/factsheets/fs369/en. Accessed July 08, 2020.
2. Murray C. J. L., Barber R. M., Foreman K. J., Christopher J. L., Murray R. M. [et al.]. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145-2191. https://doi.org/10.1016/S0140-6736(15)61340-X
3. Kessler R. C., Petukhova M., Sampson N. A., Zaslavsky A. M., Wittchenet H-U. Twelve-month and lifetime prevalence and life-time morbid risk of anxiety and mood disorders in the United States. Int. J. Methods Psychiatr. Res. 2012;21:169-184. https://doi.org/10.1002/mpr.1359
4. Henriksson M. M., Aro H. M., Marttunen M. J., Heikkinen M. E., EIsometsä E. T. [et al.]. Mental disorders and comorbidity in suicide. Am. J. Psychiatry. 1993;150:935-940. https://doi.org/10.1176/ajp.150.6.935
5. Health, United States, 2016: with chart-book on long-term trends in health. Hyatts-ville, MD: National Center for Health Statistics, 2017.
6. Diagnostic and statistical manual of mental disorders, 5th ed.: DSM-V. Washington, DC: American Psychiatric Association,2013.
7. Iznak A. F., Iznak E. V., Oleichik I. V., Medvedeva T. I. New approaches to treating depression: the effect of magnetic stimulation on the brain. Vestnik RFFI. Gumanitarnyye i obshchestvennyye nauki. – Vestnik RFBR. Humanities and social sciences. 2018;4:125-134. (In Russ.). https://doi.org/10.22404/2587-8956-2018-093-04-125-136
8. Lee G., Bae H. Therapeutic effects of phytochemicals and medicinal herbs on depression. BioMed Res. Int. 2017;2017:11. https://doi.org/10.1155/2017/6596241
9. Cuijpers P., Sijbrandij M., Koole S. L., Andersson G., Beekman A. T., Reynolds C. F. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12(2):137-148. https://doi.org/10.1002/wps.20038
10. Schramm E., Klein D. N., Elsaesser M., Furukawa T. A., Domschke K. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry. 2020;7(9):801-812. https://doi.org/10.1016/S2215-0366(20)30099-7
11. Maslenikov N. V., Tsukarzi E. E., Mosolov S. N. Transcranial magnetic stimulation in the treatment of depression and negative symptoms in schizophrenia. Psikhicheskoye zdorov’ye. – Mental health. 2013;1(80):39-44. (In Russ.).
12. Iskra D. A., Frunza D. N. Repeated transcranial magnetic stimulation in the treatment of chronic tension headaches. Vestnik Rossiyskoy voyenno-meditsinskoy akademii. – Bulletin of the Russian Military Medical Academy. 2012;3(39):34-38.(In Russ.).
13. Andreeva I. N., Akishina I. V. Transcranial electrical stimulation. Astrakhanskiy meditsinskiy zhurnal.– Astrakhan medical journal. 2012;1(7):22-27. (In Russ.).
14. Riva M. A., Bellani I., Tremolizzo L., Lorusso L., Ferrarese C., Cesana G. The Neurologist in Dante’s Inferno. Eur. Neurol. 2015;73(5-6):278-282. https://doi.org/10.1159/000381541

Keywords: depression, symptoms of depression, general magnetotherapy, Hamilton scale (HDRS)